11-39916

Hazard statements (CLP)

H315, H317, H319, H350, H411

Code

Statements

H315

Causes skin irritation

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture

Hazard pictograms

None required GHS07 GHS08 GHS09 Signalword None required WARNING

Hazard statements

None required H315 Causes skin irritation. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H350 May cause cancer <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>. H411 Toxic to aquatic life with long lasting effects.

Prevention

P201 Obtain special instructions before use None required P273 Avoid release to the environment. P280 Wear protective gloves/protective clothing/eye protection/face protection. P281 Use personal protective equipment as required.

Response

P302+P352 IF ON SKIN Wash with plenty of soap and water None required P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P332+P313 If skin irritation occurs: Get medical advice/attention. P337+P313 If eye irritation persists: Get medical advice/attention. P361 Remove/Take off immediately all contaminated clothing. P391 Collect spillage.

Hazardous Ingredients

No label required reaction mass of 2-methylbutyl salicylate and pentyl salicylate 2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-2-buten-1-ol benzophenone 99,9% 3-(4-tertbutylphenyl)propanal cerdyl methyl ether 3-phenylpropen-2-al 2-methyl-4-isopropyldihydrocinnamaldehyde 2,6-dimethyl-7-octen-2-ol 2-(2-methyl propyl)-4-hydroxy-4-methyl tetrahydropyran e- and z-oxacyclohexadec-12(+13)-en-2-one beta, gamma-hexenyl salicilate n-hexyl ortho hydroxy benzoate 7-acetyl-(1,8)-octahydro-1,1,6,7-tetramethylnapthalene linalool linalyl acetate 3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one 6,6-dimethylbicyclo[3.1.1]hept-2-ene-2-ethyl acetate paramenthen-1-ol-8

2.3 Other hazards

This substance/mixture does not contain components classified as persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. This substance/mixture contains components classified as persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

ECOLOGICAL INFORMATION

This substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. This substance/mixture contains components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

This substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher. This substance/mixture contains components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

2.1 Classification of the substance or mixture

Classification (REGULATION (EC) No 1272/2008) None required H315 Causes skin irritation.Skin corrosion/irritation (SCI)Category 2 H317 May cause an allergic skin reaction.Sensitization, skin (SS 1 / 1B)Category 1 H319 Causes serious eye irritation.Serious eye damage/eye irritation (EDI)Category 2A H350 May cause cancer <state route of exposure if it is conclusively proven that no other routes of exposure cause the hazard>. Carcinogenicity (CAR)1A, 1B H411 Toxic to aquatic life with long lasting effects.Hazardous to the aquatic environment, long-term hazard (EH C)Category 2